ArticleNeuro-oncology2014

The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.

Remco J Molenaar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.